Elizabeth Chalmers
Impact in
- Hematology top 2%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
-
- Hemophilia Treatment and Research 4
- Blood Coagulation and Thrombosis Mechanisms 2
- Platelet Disorders and Treatments 2
- Blood groups and transfusion 1
-
- Renal Diseases and Glomerulopathies 1
- Co-authors
- Ri J. Liesner (2 shared papers)Michael L. Richards (2 shared papers)SA Brown (1 shared paper)M.D. Williams (1 shared paper)Diane Stirling (1 shared paper)Angela E. Thomas (1 shared paper)David Young (1 shared paper)David M. Keeling (1 shared paper)
- Journals
- Haemophilia (2 papers)Blood (1 paper)Blood Reviews (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United KingdomAustraliaItaly
In The Last Decade
Elizabeth Chalmers
5 papers receiving 544 citations
Peers
Comparison fields: 5 of 36
- Hematology 486
- Genetics 100
- Nephrology 44
- Immunology 92
- Transplantation 9
Countries citing papers authored by Elizabeth Chalmers
This map shows the geographic impact of Elizabeth Chalmers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Chalmers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Chalmers more than expected).
Fields of papers citing papers by Elizabeth Chalmers
This network shows the impact of papers produced by Elizabeth Chalmers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Chalmers. The network helps show where Elizabeth Chalmers may publish in the future.
Co-authors
The 25 scholars most cited alongside Elizabeth Chalmers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 277 | |
| 2 | 2007 | 137 | |
| 3 | 2010 | 97 | |
| 4 | 2003 | 42 | |
| 5 | 2005 | 19 |
About Elizabeth Chalmers
Elizabeth Chalmers is a scholar working on Hematology, Nephrology, Management of Technology and Innovation, Immunology and Molecular Biology, having authored 5 papers that have together received 572 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (4 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Cancer-related gene regulation (2 papers), Platelet Disorders and Treatments (2 papers), Complement system in diseases (1 paper), Blood groups and transfusion (1 paper), Renal Diseases and Glomerulopathies (1 paper) and Blood donation and transfusion practices (1 paper). The work is most often cited by research in Hematology (486 citations), Genetics (100 citations), Nephrology (44 citations), Immunology (92 citations) and Transplantation (9 citations). Elizabeth Chalmers has collaborated with scholars based in United Kingdom, Australia and Italy. Frequent co-authors include Ri J. Liesner, Michael L. Richards, SA Brown, M.D. Williams, Diane Stirling, Angela E. Thomas, David Young, David M. Keeling, John P Hanley and Russell P. Rother. Their work appears in journals such as Haemophilia, Blood, Blood Reviews and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.